Skip to content
10-Q

Quarterly Report

OXFORD IMMUNOTEC GLOBAL PLC

0001437749-19-021535

← back to feed
Filed
Nov 5, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Oct 24, 2019 26.45M sh
Cash And Equivalents Q3 2019 · Sep 30, 2019 $184.28M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $192.84M
Current Liabilities Q3 2019 · Sep 30, 2019 $16.73M
Current Liabilities Q3 2019 · Dec 31, 2018 $18.01M
Total Liabilities Q3 2019 · Sep 30, 2019 $24M
Total Liabilities Q3 2019 · Dec 31, 2018 $18.11M
Current Assets Q3 2019 · Sep 30, 2019 $221.43M
Current Assets Q3 2019 · Dec 31, 2018 $216.78M
Total Assets Q3 2019 · Sep 30, 2019 $238.97M
Total Assets Q3 2019 · Dec 31, 2018 $232.12M
Shares Diluted Q3 2019 · Sep 30, 2018 26.03M sh
Shares Diluted Q3 2019 · Sep 30, 2018 25.87M sh
Capex Q3 2019 · Sep 30, 2018 $4.88M
Stockholders Equity Q3 2019 · Sep 30, 2018 $71.97M
Stockholders Equity Q3 2019 · Jun 30, 2018 $73.16M
Stockholders Equity Q3 2019 · Mar 31, 2018 $79.61M
Stockholders Equity Q3 2019 · Dec 31, 2017 $87.63M
Eps Diluted Q3 2019 · Sep 30, 2018 −$0.13
Eps Diluted Q3 2019 · Sep 30, 2018 −$0.78
Eps Basic Q3 2019 · Sep 30, 2018 −$0.13
Eps Basic Q3 2019 · Sep 30, 2018 −$0.78
Sga Expense Q3 2019 · Sep 30, 2018 $8.13M
Sga Expense Q3 2019 · Sep 30, 2018 $19.35M
Rd Expense Q3 2019 · Sep 30, 2018 $1.75M
Rd Expense Q3 2019 · Sep 30, 2018 $5.97M
Net Income Q3 2019 · Sep 30, 2018 −$3.48M
Net Income Q3 2019 · Sep 30, 2018 −$20.28M
Net Income Q3 2019 · Jun 30, 2018 −$6.47M
Net Income Q3 2019 · Mar 31, 2018 −$10.33M
Operating Income Q3 2019 · Sep 30, 2018 −$5.05M
Operating Income Q3 2019 · Sep 30, 2018 −$16.44M
Gross Profit Q3 2019 · Sep 30, 2018 $11.48M
Gross Profit Q3 2019 · Sep 30, 2018 $31.52M